Oklo Inc. (NYSE:OKLO - Get Free Report) insider Alexandra Renner sold 557 shares of Oklo stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $39.77, for a total value of $22,151.89. Following the sale, the insider directly owned 472,779 shares of the company's stock, valued at $18,802,420.83. This trade represents a 0.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Oklo Stock Performance
NYSE OKLO traded up $4.54 during trading hours on Tuesday, reaching $44.23. The stock had a trading volume of 13,848,404 shares, compared to its average volume of 11,377,922. Oklo Inc. has a 52-week low of $36.61 and a 52-week high of $193.84. The stock has a fifty day moving average of $46.98 and a 200 day moving average of $57.11. The stock has a market cap of $8.23 billion, a P/E ratio of -47.05 and a beta of 1.17.
Oklo (NYSE:OKLO - Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.12). The business had revenue of $1.21 million for the quarter, compared to the consensus estimate of $0.09 million. During the same period in the previous year, the company earned ($0.18) earnings per share. The company's revenue was up 11900.0% compared to the same quarter last year. On average, equities research analysts forecast that Oklo Inc. will post -0.9 EPS for the current year.
Wall Street Analyst Weigh In
OKLO has been the subject of a number of research reports. Canaccord Genuity Group decreased their target price on shares of Oklo from $125.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, August 10th. Wedbush reaffirmed an "outperform" rating and set a $110.00 price target on shares of Oklo in a research report on Tuesday, May 26th. Truist Financial reduced their price objective on Oklo from $55.00 to $51.00 and set a "hold" rating for the company in a research note on Monday, August 10th. Barclays decreased their price objective on Oklo from $82.00 to $76.00 and set an "overweight" rating for the company in a report on Wednesday, July 22nd. Finally, Guggenheim started coverage on Oklo in a report on Thursday, June 25th. They set a "neutral" rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $85.03.
Read Our Latest Research Report on Oklo
Institutional Trading of Oklo
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. NBC Securities Inc. raised its position in shares of Oklo by 75.0% in the fourth quarter. NBC Securities Inc. now owns 350 shares of the company's stock worth $25,000 after acquiring an additional 150 shares during the period. Vantage Point Financial LLC grew its position in shares of Oklo by 0.8% during the 4th quarter. Vantage Point Financial LLC now owns 21,222 shares of the company's stock valued at $1,523,000 after acquiring an additional 169 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Oklo by 6.6% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 2,800 shares of the company's stock valued at $313,000 after acquiring an additional 174 shares during the period. Citizens Financial Group Inc. RI increased its stake in shares of Oklo by 1.0% in the 1st quarter. Citizens Financial Group Inc. RI now owns 18,704 shares of the company's stock valued at $928,000 after purchasing an additional 182 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Oklo by 0.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 70,433 shares of the company's stock valued at $3,493,000 after purchasing an additional 183 shares in the last quarter. Institutional investors and hedge funds own 85.03% of the company's stock.
Key Headlines Impacting Oklo
Here are the key news stories impacting Oklo this week:
Oklo Company Profile
(
Get Free Report)
Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.
The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Oklo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oklo wasn't on the list.
While Oklo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.